Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 3Vomiting 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Sleep Wake Disorders 1Opioid-Related Disorders 1Neoplasms 1Nausea 1Lymphoma, Follicular 1Cancer Pain 1Breakthrough Pain 1

Interventions

Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Breakthrough Pain × Methadone × Clear all
NCT00125294 2017-09-25

Sublingual Methadone for the Management of Cancer Breakthrough Pain

AHS Cancer Control Alberta

Phase 1 Completed
10 enrolled

Cancer Pain, Neoplasms, Pain, Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡